Table 1.

Inhibition of platelet adhesion on VEGF-stimulated endothelial cells by blocking antibodies

Incubation with mAb or other inhibitorWith endothelial cellsWith platelets
% inhibition (SEM)
IgG 17  (16) 20  (15)  
CD31 (PECAM) 0  (8) 4  (6)  
Gp-Ib 0  (15) 14  (15) 
P-selectin 0  (49) 33  (8)  
Tissue factor 92  (6) 100  (8) 
Fibrin(ogen) 0  (18) 89  (21)* 
Fibrin 0  (22) 94  (10) 
αvβ3 integrin (LM609) 0  (9) 61  (12)* 
reopro (αIIbβ3 and αvβ30  (20) 72  (22)* 
Thrombin inhibitor (I1285) ND 100  (3) 
SU5416 (VEGF-R-blocker) 86  (12) ND 
Incubation with mAb or other inhibitorWith endothelial cellsWith platelets
% inhibition (SEM)
IgG 17  (16) 20  (15)  
CD31 (PECAM) 0  (8) 4  (6)  
Gp-Ib 0  (15) 14  (15) 
P-selectin 0  (49) 33  (8)  
Tissue factor 92  (6) 100  (8) 
Fibrin(ogen) 0  (18) 89  (21)* 
Fibrin 0  (22) 94  (10) 
αvβ3 integrin (LM609) 0  (9) 61  (12)* 
reopro (αIIbβ3 and αvβ30  (20) 72  (22)* 
Thrombin inhibitor (I1285) ND 100  (3) 
SU5416 (VEGF-R-blocker) 86  (12) ND 

VEGF indicates vascular endothelial growth factor; mAb, monoclonal antibody; IgG, immunoglobulin G; PECAM, platelet-endothelial cell adhesion molecule; Gp-Ib, glycoprotein-Ib; ND, not determined; HUVEC, human umbilical vein endothelial cell.

The fluorescence-labeled platelets were allowed to adhere to the HUVECs for 30 minutes and subsequently the remaining unbound platelets were washed away. Platelet adhesion was determined by a fluorescence plate reader. The mean percentage of inhibition is calculated from 3 independent experiments (± SEM). Significant differences (

*

=P < .05;

= P < .01) were calculated with the Student t test. Negative inhibition values were set at zero.

or Create an Account

Close Modal
Close Modal